Resmed (RMD) Net Equity Issued and Repurchased (2009 - 2026)
Resmed's (RMD) quarterly Net Equity Issued and Repurchased came in at $29.3 million in Q2 2026, down 2.79% on a YoY basis from $30.2 million in Q2 2025, and up 294.7% quarter-over-quarter from $7.4 million in Q1 2026.
Powered by 
Analysis
Resmed (RMD) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
Resmed (RMD) has reported Net Equity Issued and Repurchased for 18 consecutive years, with $29.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Equity Issued and Repurchased fell 2.79% year-over-year to $29.3 million; the trailing twelve-month figure through Jun 2026 stood at $74.5 million (changed 0.09% YoY), and the FY2026 full-year result was $74.5 million, changed 0.09% from the prior year.
- Net Equity Issued and Repurchased advanced to $29.3 million in Q2 2026 per RMD's latest filing, from $7.4 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $30.2 million in Q2 2025 and bottomed at $983000.0 in Q1 2023.
- Historically, Net Equity Issued and Repurchased has averaged $15.3 million across 5 years, with a median of $14.3 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Net Equity Issued and Repurchased soared 1840.69% in 2022, then sank 65.07% in 2023.
- Over 5 years, Net Equity Issued and Repurchased stood at $22.1 million in 2022, then retreated by 11.48% to $19.5 million in 2023, then jumped by 37.66% to $26.9 million in 2024, then rose by 9.97% to $29.6 million in 2025, then declined by 0.82% to $29.3 million in 2026.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $29.3 million, $7.4 million, and $29.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.49 Bn | 174.54 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 142.30 Bn | 137.21 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.24 Bn | 108.04 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 105.51 Bn | 102.03 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 65.13 Bn | 64.83 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.20 Bn | 47.05 Bn | 1.35 Bn | - |
| 7 | Dexcom | 33.79 Bn | 31.84 Bn | 830.00 Mn | - |
| 8 | Resmed | 32.01 Bn | 30.54 Bn | 861.22 Mn | 29.31 Mn |
| 9 | Alcon | 31.98 Bn | 30.52 Bn | 1.68 Bn | - |
| 10 | Steris | 20.35 Bn | 19.89 Bn | 684.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.31 Mn |
| Mar 31, 2026 | 7.43 Mn |
| Dec 31, 2025 | 29.56 Mn |
| Sep 30, 2025 | 8.21 Mn |
| Jun 30, 2025 | 30.16 Mn |
| Mar 31, 2025 | 9.02 Mn |
| Dec 31, 2024 | 26.88 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 27.70 Mn |
| Mar 31, 2024 | 4.89 Mn |
| Dec 31, 2023 | 19.52 Mn |
| Sep 30, 2023 | 983,000.00 |
| Jun 30, 2023 | 23.49 Mn |
| Mar 31, 2023 | 983,000.00 |
| Dec 31, 2022 | 22.06 Mn |
| Sep 30, 2022 | 2.61 Mn |
| Jun 30, 2022 | 21.12 Mn |
| Mar 31, 2022 | 2.81 Mn |
| Dec 31, 2021 | 19.10 Mn |
| Sep 30, 2021 | 4.35 Mn |
API Access
Resmed Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "RMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();